Kalpana Bakshi

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

John D. Grainger, Franco Locatelli, Thirachit Chotsampancharoen et al. · The Lancet · 2015 · 215 citations

Pharmacy, Pediatrics, Pharmacotherapy +9

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study

James B. Bussel, Purificación García de Miguel, Jenny M. Despotovic et al. · The Lancet Haematology · 2015 · 195 citations

Medicine, Pediatrics, Pharmacology +8

Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the <scp>EXTEND</scp> study

Russell K. Brynes, Attilio Orazi, Dickens Theodore et al. · American Journal of Hematology · 2015 · 64 citations · Full text

Medicine, Hematology, Pathology +12

Talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Updated TRIMM-2 results.

Bhagirathbhai Dholaria, Katja Weisel, María‐Victoria Mateos et al. · Journal of Clinical Oncology · 2023 · 63 citations

Medicine, Pharmacology, Pharmacotherapy +17

Combination Therapy with Zidovudine Prevents Selection of Human Immunodeficiency Virus Type 1 Variants Expressing High-Level Resistance to L-697,661, a Nonnucleoside Reverse Transcriptase Inhibitor

Schlomo Staszewski, F Massari, Astrid Kober et al. · The Journal of Infectious Diseases · 1995 · 54 citations

Life Sciences, Infectious Diseases, Pharmacology +17